arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Opus Genetics, Inc.

IRD Health Care Biotechnology: Pharmaceutical Preparations
$3.47
▼ -15.8% Today
as of Oct 23, 16:49 ET
Last 30 days -41.88% Sep 14 → Oct 23
$3.27 $3.99 $4.72 $5.44 $6.17 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$3.79
High
$3.80
Low
$3.44
Volume
$1M
Avg Vol
$1M
Mkt Cap
$375M
P/E (TTM)
—
Beta
—
52w High
$7.07
52w Low
$1.70
Div Yield
—
Shares Out
$83M

Recent Press Releases & News last 60 days · 19 items

Oct 21 · 11:00 PR GlobeNewswire
Opus Genetics Announces FDA Clearance of IND Application for OPGx-RDH12 Gene Therapy for Inherited Childhood Blindness
Oct 16 · 17:58 Stocktwits
Opus Genetics Secures FDA Approval For Eye Drops – Set To Receive Milestone Payment
Oct 16 · 17:37 MT Newswires
Opus Genetics Says FDA Approves Supplemental Application for Presbyopia Treatment
▸ Show all 19 press releases & news Free account →

IRD earnings at a glance

The options market is pricing a move of about ±6.7% after the report, a range of roughly $3.24 to $3.70 from today's $3.47. Over its last 2 reports the stock rose the next day 1 time and fell 1, moving ±0.6% on average; after the most recent report on May 12, 2026 it moved +1.2%. That means options currently expect more movement than IRD has typically delivered. IRD beat the consensus EPS estimate in 3 of its last 4 reported quarters. Implied volatility is currently 53%. The share price of $3.47 sits in the middle of its 52-week range.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$1.70
$7.07
33% of range
Avg surprise (last 4)
-74.1%
Avg reaction (last 2)
+0.6%
50% positive
Latest IV / EM
53%
EM ±6.7% · $5 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.75$-0.50$-0.25$0.00$0.25 Actual $-0.28Actual $-0.24Actual $0.25Actual $-0.29Actual $-0.30Actual $-0.29Actual $-0.32Est $-0.34Actual $-0.12Est $-0.25Actual $-0.12Est $-0.14Actual $-0.75Est $-0.16Actual $-0.14 MarJunSepMarJunSepMar/2025Jun/2025Sep/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-66M$-48M$-30M$-13M$5M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.14 — — — — financials
Tue May 12, 2026Mar/2026 $-0.75 $-0.16 -368.8% -134.4% +1.2% earnings
Wed Nov 12, 2025Sep/2025 $-0.12 $-0.14 +14.3% — — earnings
Wed Aug 13, 2025Jun/2025 $-0.12 $-0.25 +52.0% — — earnings
Thu May 15, 2025Mar/2025 $-0.32 $-0.34 +5.9% — 0.0% earnings
Mon Sep 30, 2024Sep 2024 $-0.29 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.30 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.29 — — — — financials
Sat Sep 30, 2023Sep 2023 $0.25 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.24 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.28 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$755,000$2M—$3M$3M$4M—$4M
Cost of revenue————————
Gross profit————————
Operating income$-16M$-14M—$-8M$-9M$-10M—$-8M
Net income$-8M$-66M—$-17M$-7M$-8M—$-8M
EPS (diluted)$-0.14$-0.75—$-0.25$-0.12$-0.24—$-0.29

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$89M$60M$45M$31M$32M$42M$30M$37M
Inventory————————
Total current assets$93M$67M$50M$36M$38M$48M$37M$40M
Total assets$93M$67M$50M$36M$39M$48M$37M$40M
Long-term debt$35M$1M$1M$1M$1M—$0—
Total liabilities$106M$88M$35M$30M$21M$24M$11M$6M
Total equity$-13M$-46M$15M$6M$17M$5M$7M$34M

Implied volatility — last 90 days

26%302%579%856%1133% Jun 07 — IV 81% · EM ±11.2%Jun 08 — IV 808% · EM ±106.7%Jun 10 — IV 54% · EM ±6.4%Jun 23 — IV 60% · EM ±12.3%Jun 26 — IV 26% · EM ±5.0%Jun 29 — IV 35% · EM ±6.3%Jul 15 — IV 1119% · EM ±66.1%Jul 20 — IV 291% · EM ±68.8%Jul 21 — IV 225% · EM ±52.3%Jul 22 — IV 736% · EM ±168.3%Jul 23 — IV 176% · EM ±39.5%Jul 24 — IV 776% · EM ±171.6%Jul 27 — IV 750% · EM ±156.7%Jul 28 — IV 265% · EM ±54.3%Jul 29 — IV 331% · EM ±66.3%Jul 30 — IV 572% · EM ±112.0%Aug 03 — IV 295% · EM ±52.2%Aug 04 — IV 446% · EM ±76.8%Aug 06 — IV 391% · EM ±63.2%Aug 10 — IV 533% · EM ±73.8%Aug 11 — IV 468% · EM ±61.9%Aug 13 — IV 626% · EM ±73.9%Aug 14 — IV 496% · EM ±54.8%Aug 17 — IV 722% · EM ±60.3%Aug 18 — IV 787% · EM ±56.9%Aug 20 — IV 1133% · EM ±47.3%Aug 24 — IV 53% · EM ±11.1%Aug 25 — IV 172% · EM ±35.3%Aug 26 — IV 246% · EM ±49.3%Aug 27 — IV 86% · EM ±16.9%Sep 01 — IV 394% · EM ±67.9%Sep 02 — IV 171% · EM ±28.6%Sep 03 — IV 382% · EM ±61.8%Sep 04 — IV 267% · EM ±41.8%Sep 07 — IV 301% · EM ±41.8%Sep 08 — IV 183% · EM ±24.2%Sep 09 — IV 127% · EM ±16.0%Sep 10 — IV 171% · EM ±20.2%Sep 11 — IV 313% · EM ±34.6%Sep 14 — IV 391% · EM ±32.7%Sep 15 — IV 398% · EM ±28.8%Sep 16 — IV 250% · EM ±14.8%Sep 17 — IV 272% · EM ±11.4%Sep 21 — IV 99% · EM ±20.6%Sep 22 — IV 92% · EM ±18.9%Sep 23 — IV 97% · EM ±19.5%Sep 24 — IV 63% · EM ±12.3%Sep 25 — IV 126% · EM ±24.2%Sep 28 — IV 106% · EM ±18.8%Sep 29 — IV 94% · EM ±16.1%Sep 30 — IV 114% · EM ±19.1%Oct 01 — IV 168% · EM ±27.1%Oct 02 — IV 56% · EM ±8.7%Oct 06 — IV 150% · EM ±19.8%Oct 07 — IV 53% · EM ±6.7%

Sector peers

EBS
Emergent BioSolutions Inc.
$363M $6.23+0.5%
RLMD
Relmada Therapeutics, Inc.
$390M $3.27+1.9%
TTRX
Turn Therapeutics Inc.
$396M $10.28+1.3%
BNTC
Benitec Biopharma Inc.
$334M $8.65+1.8%
PRLD
Prelude Therapeutics Incorporated
$302M $3.63-0.6%
DMAC
DiaMedica Therapeutics Inc.
$450M $8.72+0.3%

IRD earnings FAQ

What is IRD's expected move for earnings?

Options currently price a move of about ±6.7%, or $0.23 per share either way from $3.47.

How does IRD stock usually react to earnings?

Across the last 2 reports the average next-day move was ±0.6%, up 1 times and down 1 times.

What is IRD's implied volatility?

IRD's at-the-money implied volatility is about 53% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in